3D Bioprinting Regulations: a UK/EU Perspective
Authors:
Open Access
- 1 March 2017
- journal article
- other
- Published by Cambridge University Press (CUP) in European Journal of Risk Regulation
- Vol. 8 (2) , 441-447
Abstract
This report introduces the challenges 3D bioprinting poses to the existing legal regime across bioethics, safety, regenerative medicine, and tissue engineering. We briefly review the 3D bioprinting technology and look into the relevant regulatory instruments for the pre-printing, printing, and post-printing stages. Special attention is paid to the applications of the EU Advanced Therapy Medicinal Products Regulation and the new Medical Device Regulation.Keywords
This publication has 2 references indexed in Scilit:
- A 3D Bioprinting Exemplar of the Consequences of the Regulatory Requirements on Customized ProcessesRegenerative Medicine, 2015
- The Human Transplantation (Wales) Act 2013: an Act of Encouragement, not EnforcementThe Modern Law Review, 2015